RESUMEN
OBJECTIVE AND IMPORTANCE: Huntington's disease (HD) produces debilitating motor abnormalities that are poorly responsive to medical therapy. Deep brain stimulation (DBS) may offer a treatment option for afflicted patients, but its role in the management of HD remains unclear. In the present case, DBS leads were implanted bilaterally into the posteroventral globus pallidus internus (GPi) to control disabling and medically intractable choreathetosis in a severely affected HD patient. The surgical procedure, intraoperative electrophysiological findings, and 12-month postoperative course, with patient video, are presented. CLINICAL PRESENTATION: This 41-year-old man with genetically confirmed HD developed motor symptoms at age 28. He had completed multiple medical trials without alleviation of his progressive and debilitating choreathetosis. Extensive clinical assessment, including neuropsychological testing, was performed to determine surgical candidacy. INTERVENTION: DBS leads were bilaterally implanted, under stereotactic guidance, into the posteroventral GPi. Disease progression and symptom control were assessed at regular postoperative intervals. Bilateral pallidal stimulation produced a dramatic reduction in choreathetoid movements and improvement in overall motor functioning. The patient also exhibited normalization of body weight, mood, and energy level, as well as improved performance of activities of daily living. These effects were sustained at 1 year after surgery. CONCLUSION: The clinical benefits of DBS observed in this HD patient were comparable to those reported in other hyperkinetic disorders and demonstrate that pallidal stimulation can provide long-term alleviation of HD-associated choreathetosis.
Asunto(s)
Atetosis/terapia , Corea/terapia , Estimulación Encefálica Profunda/métodos , Globo Pálido/fisiología , Enfermedad de Huntington/terapia , Adulto , Atetosis/complicaciones , Atetosis/fisiopatología , Corea/complicaciones , Corea/fisiopatología , Humanos , Enfermedad de Huntington/complicaciones , Enfermedad de Huntington/fisiopatología , Masculino , Monitoreo Intraoperatorio/métodosRESUMEN
Cockayne syndrome manifests a spectrum of neurological dysfunction that includes medically intractable movement disorders. Deep brain stimulation has not been well studied in such rare neurodegenerative conditions. In this case, stimulation of the ventral intermediate nucleus of the thalamus was used to manage severe motor symptoms in a young man with Cockayne syndrome. There was a marked and progressive response to thalamic stimulation within weeks of surgery. These results suggest that patients with Cockayne syndrome should be considered for deep brain stimulation to treat refractory movement disorders.
Asunto(s)
Síndrome de Cockayne/terapia , Estimulación Encefálica Profunda , Hipercinesia/terapia , Adolescente , Síndrome de Cockayne/diagnóstico , Síndrome de Cockayne/fisiopatología , Evaluación de la Discapacidad , Dominancia Cerebral/fisiología , Electrodos Implantados , Estudios de Seguimiento , Humanos , Hipercinesia/diagnóstico , Hipercinesia/fisiopatología , Imagen por Resonancia Magnética , Masculino , Examen Neurológico , Tomografía Computarizada por Rayos X , Núcleos Talámicos Ventrales/fisiopatologíaRESUMEN
Parkinson's disease is a common neurodegenerative disorder, affecting over 100,000 Canadians. With advances in medical and surgical treatments, clients are living longer and fuller lives. However, as the disease progresses those with Parkinson's continue to face a variety of deficits in their occupational performance. Although this is the domain of occupational therapists, very little is described in the occupational therapy literature related to Parkinson's. This article addresses this void by describing these deficits and current measurement tools that can be used to evaluate the impact on people living with Parkinson's disease. Although several tools are cited, three tools are recommended for an occupational therapy evaluation of individuals with Parkinson's disease: the Canadian Occupational Performance Measure, the Unified Parkinson's Disease Rating Scale and the Parkinson's Disease Questionnaire.
Asunto(s)
Terapia Ocupacional , Evaluación de Resultado en la Atención de Salud , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/rehabilitación , Actividades Cotidianas , Anciano , Humanos , Calidad de Vida , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Encuestas y CuestionariosRESUMEN
The main neural transplantation strategy in Parkinson disease (PD) has been focused on reinnervating the striatum. The clinical results reported in patients who receive transplants have been limited and do not justify the use of neural transplantation as a routine therapeutic procedure for PD. Identifying the optimal target for transplantation may be one of the critical factors for optimizing clinical outcomes. Evidence from preclinical studies indicates that simultaneous intrastriatal and intranigral grafts (double grafts) may produce a more complete functional recovery. The authors report the clinical and positron emission tomography (PET) scanning results in three patients enrolled in a safety and feasibility pilot study who received double grafts and who have been followed for up to 13 months posttransplantation. Patients included in the study had idiopathic PD. All patients underwent detailed assessments before and after surgery, in accordance with the Core Assessment Program for Intracerebral Transplantation. The patients received implants of fetal mesencephalic cell suspensions in the putamen and substantia nigra (SN) bilaterally. There were no intraoperative or perioperative complications. Follow-up PET scans demonstrated an increase in the mean fluorodopa uptake constant values in the putamen and SN 12 months postsurgery. Improvements were also noted in the total Unified Parkinson's Disease Rating Scale, Hoehn and Yahr, Schwab and England, and pronation/supination scores after transplantation. The authors demonstrate the feasibility of reinnervating the SN and striatum by using a double transplant strategy in humans.